Pulmonary Embolism: Clinical Trials

780 trials for Pulmonary Embolism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

427 completed, 123 unknown, 101 recruiting, 47 terminated. 222 Not applicable, 81 Phase 3, 69 Phase 4, 36 Phase 2, 15 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable222Completed 120, Recruiting 40, Unknown 28, Terminated 12, Active not recruiting 8, Not yet recruiting 7, Withdrawn 5, Suspended 2
Phase 381Completed 48, Recruiting 11, Terminated 11, Unknown 4, Withdrawn 4, Active not recruiting 3
Phase 469Completed 38, Terminated 7, Unknown 7, Withdrawn 6, Recruiting 5, Active not recruiting 4, Not yet recruiting 2
Phase 236Completed 23, Terminated 5, Unknown 4, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1
Phase 115Completed 10, Unknown 3, Terminated 2
Early Phase 111Completed 6, Recruiting 2, Not yet recruiting 1, Terminated 1, Unknown 1

Follow Pulmonary Embolism: new trials by email Literature Review of Pulmonary Embolism trials Research Report on Pulmonary Embolism

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE
Ultrasound-facilitated, catheter-directed lower-dose fibrinolysis, Tissue Plasminogen Activator - Pulmonary Embolism, Right Ventricular Dysfunction
SuspendedBrigham and Women's Hospital602027-01-012026-01-21
Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism
edoxaban, Apixaban - Venous Thromboembolism, Active Cancer
Phase 4Not yet recruitingSamsung Medical Center23002026-11-012026-10-01
Exclusion of Left Atrial Appendage Thrombus in Emergency Department Patients With Atrial Fibrillation Undergoing CT to Assess for Pulmonary Embolus: A Feasibility Study
Delayed Un-gated CT Scan for Left Atrial Appendage Thrombus, Delayed Gated CT Scan for Left Atrial Appendage Thrombus - Atrial Fibrillation (AF), Pulmonary Embolism (PE)
Not applicableNot yet recruitingNorthwell Health602026-10-012026-10-13
Pilot Study Evaluating Catheter Directed Thrombolysis Device in Acute Intermediate Risk Pulmonary Embolism
Thrombolysis Catheter - Pulmonary Embolism (PE), Pulmonary Embolism With Right Ventricle Enlargement
Not applicableNot yet recruitingFlow Medical Solutions, Inc.202026-10-012026-07-02
Vortosiran for VTE Prevention
Vortosiran, Placebo - Venous Thromboembolism (VTE), Cancer
Phase 2Not yet recruitingRibocure Pharmaceuticals AB1502026-10-012026-09-30
Multimodal Physiologic State Intelligence Study
OMNIPHYS Multimodal Ultrasound Imaging System - Heart Failure, Cardiomyopathies
Enrolling by invitationTruway Health, Inc.250002026-09-022026-09-10
Risk Factors of Venous Thrombotic Event in Interstitial Lung Disease
Interstitial Lung Disease, Venous Thromboembolism
Not yet recruitingSohag University1002026-09-012026-09-22
Decision Aid for Anticoagulation Duration After Unprovoked Venous Thromboembolism
DECIDE-VTE Patient Decision Aid - Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT)
Not applicableNot yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre8502026-09-012026-06-24
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
REGN7508, Apixaban - Venous Thromboembolism (VTE)
Phase 3RecruitingRegeneron Pharmaceuticals16002026-08-262026-10-21
Vibrato Aspiration System - Simple, Intuitive Approach to Clot Removal in Acute Pulmonary Embolism - a Safety & Feasibility Study
Mechanical Thrombectomy - Pulmonary Embolism Acute
Not applicableRecruitingVicora, Inc.102026-08-212026-08-25
Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism
mobile venous thromboembolism application (mVTEA) - Venous Thromboembolism, Pulmonary Thromboembolisms
Not applicableRecruitingNavy General Hospital, Beijing29722026-08-202026-09-09
Predictors of Pulmonary Embolism in Interstitial Lung Disease With Worsening Symptoms
Pulmonary Embolism, Interstitial Lung Disease
Not yet recruitingAssiut University702026-08-012026-07-27
Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease
Apixaban - Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT)
Phase 4Not yet recruitingJames Bayley502026-08-012026-07-20
Prospective Cohort of Acute Cardiology Referrals in an Ambulatory Day-Hospital Setting
Acute Coronary Syndromes, Heart Failure
Not yet recruitingAssistance Publique - Hôpitaux de Paris250002026-08-012026-06-30
Pulmonary Embolism in Patients With Acute Heart Failure (PEHF Study)
Systematic screening for pulmonary embolism in all patients using a guideline-recommended diagnostic algorithm - Acute Heart Failure (AHF), Pulmonary Embolism (Diagnosis)
Not applicableRecruitingUniversity Hospital, Angers7402026-07-152026-07-17
Role of n On-contrast Chest CT (NCCT) Based CT V: Q in Patients With Acute Pulmonary Embolism (aPE)
Additional CT acquisition at low dose (1- 2 mSv) - Pulmonary Embolism (Diagnosis), Pulmonary Embolism Acute
Not applicableRecruitingMassachusetts General Hospital7502026-07-152026-09-11
Evaluation of the Magneto eTrieve™ PE Kit for Endovascular Thrombectomy in Subjects With Acute Pulmonary Embolism
eTrieve PE Kit - Pulmonary Embolism
Not applicableNot yet recruitingMagneto Thrombectomy Solutions1302026-07-012025-09-29
Pulmonary Embolism Registry From Short-Term Emergency to Long-Term Follow-Up and Surveillance
Routine clinical care (no study intervention) - Venous Thromboembolism (VTE), Chronic Thromboembolic Pulmonary Hypertension
RecruitingAzienda Ospedaliero-Universitaria Careggi50002026-06-192026-10-15
Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)
Ultrasound assisted Thrombolysis, Percutaneous Embolectomy, Heparin - Pulmonary Embolism
Phase 3RecruitingJesper Kjaergaard2102026-06-172026-07-02
Statins to Prevent Cancer Associated Blood Clots
Rosuvastatin, Placebo Drug - Venous Thromboembolism, Cancer
Phase 4RecruitingBrigham and Women's Hospital40002026-06-112026-09-16

Showing 20 of 780. Sign in to see all of them.

Narrower conditions

Venous Thrombosis (293)  ·  Venous Thromboembolism (184)  ·  Thrombosis (67)  ·  Atrial Fibrillation (47)  ·  Thromboembolism (32)  ·  Neoplasms (30)  ·  Disease (28)  ·  COVID-19 (26)  ·  Hypertension, Pulmonary (20)  ·  Stroke (20)  ·  Cardiovascular Diseases (19)  ·  Hemorrhage (19)  ·  Embolism (17)  ·  Heart Failure (17)

Broader conditions

Respiratory Tract Diseases (775)  ·  Vascular Diseases (772)  ·  Embolism and Thrombosis (766)  ·  Embolism (763)  ·  Lung Diseases (763)  ·  Cardiovascular Diseases (761)  ·  Thrombosis (258)  ·  Pathological Conditions, Signs and Symptoms (190)  ·  Thromboembolism (174)  ·  Pathologic Processes (167)  ·  Heart Diseases (106)  ·  Nervous System Diseases (57)  ·  Infections (47)  ·  Disease Attributes (46)  ·  Arrhythmias, Cardiac (45)

Interventions

Enoxaparin (43)  ·  Rivaroxaban (36)  ·  apixaban (27)  ·  Heparin, Low-Molecular-Weight (24)  ·  Warfarin (24)  ·  Dalteparin (20)  ·  Heparin (20)  ·  Tissue Plasminogen Activator (17)  ·  Fondaparinux (14)  ·  Tinzaparin (11)  ·  Aspirin (10)  ·  Blood Specimen Collection (10)  ·  Nadroparin (9)  ·  Standard of Care (8)  ·  edoxaban (8)

Sponsors

Brigham and Women's Hospital (26)  ·  University Hospital, Brest (19)  ·  Assistance Publique - Hôpitaux de Paris (17)  ·  Bayer (15)  ·  Assiut University (13)  ·  Centre Hospitalier Universitaire de Saint Etienne (10)  ·  McMaster University (10)  ·  University Hospital, Angers (10)  ·  Ottawa Hospital Research Institute (9)  ·  University of Utah (9)  ·  Wake Forest University Health Sciences (9)  ·  Bristol-Myers Squibb (8)  ·  Inari Medical (8)  ·  Boston Scientific Corporation (7)  ·  China-Japan Friendship Hospital (7)

Countries

United States (227)  ·  France (135)  ·  Canada (73)  ·  China (62)  ·  Spain (59)  ·  Italy (56)  ·  Germany (53)  ·  United Kingdom (50)  ·  Netherlands (49)  ·  Switzerland (42)  ·  Denmark (36)  ·  Belgium (35)  ·  Poland (31)  ·  Austria (30)  ·  Russia (30)

Top investigators

Samuel Z. Goldhaber, MD (6)  ·  Gregory Piazza, MD, MS (4)  ·  Gualtiero Palareti, MD (4)  ·  Samuel Z Goldhaber, MD (4)  ·  Shirley Wang, PhD, ScM (4)  ·  Cecilia Becattini, MD (3)  ·  Christopher Puccini, MD (3)

Results publications

PMID 33779986, PMID 33086312, PMID 33337539, PMID 34127618, PMID 35570249, PMID 19920268, PMID 20696966, PMID 22863355, PMID 23279103, PMID 23306310, PMID 27959702, PMID 28617144, PMID 28762617, PMID 29452956, PMID 29649055, PMID 30633959, PMID 33502773, PMID 33857326, PMID 34622445, PMID 35244208, PMID 35876829, PMID 36413425, PMID 37591523, PMID 39454884, PMID 40163217, PMID 40391253, PMID 10826469, PMID 11982463, PMID 12131409, PMID 14715365, PMID 15262836, PMID 15319720, PMID 16009794, PMID 16307934, PMID 16432055, PMID 16456434, PMID 16598645, PMID 16926353, PMID 16960155, PMID 17065639, PMID 17113889, PMID 17215729, PMID 17289685, PMID 17723125, PMID 17851566, PMID 17855670, PMID 17855671, PMID 17940483, PMID 18178417, PMID 18424324

NIH funding

2023 (5), 2016 (3), 2018 (3), 2025 (3), 2015 (2), 2019 (2), 1UM1HL113203-01A1 (1), 2004 (1), 2008 (1), 2014 (1), 2017 (1), G12MD007600 (1), K23HL132054 (1), K23HL145114 (1), P30CA015083 (1)